Figure 2From: Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD ratsPathological changes of the lungs in control rats and COPD model rats that were treated with vehicles, AICAR and/or resveratrol at week 20 (H & E stained). (A) Control rats; (B) COPD rats with vehicle; (C) COPD rats with AICAR treatment; and (D) COPD rats with resveratrol treatment. Amplification ×200. Scale bar, 20 μm.Back to article page